HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Momtazmanesh Selected Research

Sara Momtazmanesh Research Topics

Disease

3COVID-19
01/2023 - 07/2020
2Multiple Sclerosis
01/2022 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2020
1Inflammation (Inflammations)
12/2023
1Narcolepsy
12/2023
1Disorders of Excessive Somnolence (Hypersomnia)
12/2023
1Cataplexy
12/2023
1Melanoma (Melanoma, Malignant)
07/2023
1Ischemic Stroke
01/2023
1Cognitive Dysfunction
01/2023
1Infections
01/2023
1Pathologic Constriction (Stenosis)
09/2022
1Disseminated Intravascular Coagulation
01/2022
1Endocarditis
01/2022
1Eosinophilia
01/2022
1Leukocytosis (Pleocytosis)
01/2022
1Lymphopenia (Lymphocytopenia)
01/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Stroke (Strokes)
01/2022
1Neoplasms (Cancer)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
07/2020
1Autism Spectrum Disorder
07/2020
1Schizophrenia (Dementia Praecox)
01/2019

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2020
2CytokinesIBA
12/2023 - 01/2019
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 01/2022
1OrexinsIBA
12/2023
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2023
1Immune Checkpoint InhibitorsIBA
07/2023
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2023
1Histamine H2 AntagonistsIBA
01/2023
1Famotidine (Pepcid)FDA LinkGeneric
01/2023
1Phenobarbital (Luminal)FDA Link
09/2022
1Anti-Bacterial Agents (Antibiotics)IBA
01/2022
1Immunoglobulin A (IgA)IBA
01/2022
1Immunoglobulin E (IgE)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1Nerve Growth Factors (Neurotrophins)IBA
01/2022
1VaccinesIBA
01/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2020
1sulforaphaneIBA
07/2020

Therapy/Procedure

2Immunotherapy
07/2023 - 01/2022
1Thrombectomy
01/2023
1Hematopoietic Stem Cell Transplantation
01/2022
1Antibiotic Prophylaxis
01/2022
1Transcranial Magnetic Stimulation
01/2022
1Radiotherapy
01/2021
1Drug Therapy (Chemotherapy)
01/2021
1Therapeutics
07/2020